第一单位：
Department of Dermatology, Center for Dermatooncology, Eberhard Karls University of Tübingen, Tübingen, Germany.
作者：
Claus,Garbe [1]
;
Ulrike,Keim [1]
;
Teresa,Amaral [1]
;
Carola,Berking [2]
;
Thomas K,Eigentler [3]
;
Lukas,Flatz [1]
;
Anja,Gesierich [4]
;
Ulrike,Leiter [1]
;
Rudolf,Stadler [5]
;
Cord,Sunderkötter [6]
;
Thomas,Tüting [7]
;
Jochen,Utikal [8]
;
Uwe,Wollina [9]
;
Lisa,Zimmer [10]
;
Christos C,Zouboulis [11]
;
Paolo A,Ascierto [12]
;
Alexander M M,Eggermont [13]
;
Jean-Jacques,Grob [14]
;
Axel,Hauschild [15]
;
Lidija Kandolf,Sekulovic [16]
;
Georgina V,Long [17]
;
Jason J,Luke [18]
;
Olivier,Michielin [19]
;
Ketty,Peris [20]
;
Dirk,Schadendorf [10]
;
John M,Kirkwood [21]
;
Paul C,Lorigan [22]
;
Central Malignant Melanoma Registry (CMMR)
作者单位：
Department of Dermatology, Center for Dermatooncology, Eberhard Karls University of Tübingen, Tübingen, Germany.
[1]
Department of Dermatology, University Hospital Erlangen, Erlangen, Germany.
[2]
Department of Dermatology, Skin Cancer Center, Charité Berlin, Berlin, Germany.
[3]
Department of Dermatology, University Hospital Wuerzburg, Wuerzburg, Germany.
[4]
Department of Dermatology, Johannes Wesling Hospital Minden, Ruhr-University of Bochum, Minden, Germany.
[5]
Department of Dermatology and Venereology, University Hospital Halle, Halle, Germany.
[6]
Department of Dermatology, University Hospital Magdeburg, Magdeburg, Germany.
[7]
Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.;Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany.
[8]
Department of Dermatology and Allergology, Municipal Hospital of Dresden, Dresden, Germany.
[9]
Department of Dermatology, University Hospital Essen, Essen, Germany.;German Cancer Consortium, Heidelberg Partner Site Essen, Essen, Germany.
[10]
Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany.
[11]
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy.
[12]
Princess Máxima Center, Utrecht, the Netherlands.;University Medical Center Utrecht, Utrecht, the Netherlands.;Comprehensive Cancer Center Munich, Munich, Germany.
[13]
Dermatology and Skin Cancer Department, APHM Timone, Aix-Marseille University, Marseille, France.
[14]
Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.
[15]
Department of Dermatology, Faculty of Medicine, Military Medical Academy, Belgrade, Serbia.
[16]
Melanoma Institute Australia, The University of Sydney, Mater Hospital, Sydney, Australia.;Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
[17]
Cancer Immunotherapeutic Center of UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA.
[18]
Department of Medical Oncology, Lausanne University Hospital, Lausanne, Switzerland.
[19]
Institute of Dermatology, Catholic University of the Sacred Heart, Rome, Italy.;IRCCS, Fondazione Policlinico Universitario A. Gemelli, Rome, Italy.
[20]
Melanoma and Skin Cancer Program, Hillman Cancer Research Pavilion Laboratory, University of Pittsburgh Cancer Institute, Pittsburgh, PA.
[21]
Division of Cancer Sciences, The Christie NHS Foundation Trust, The University of Manchester, Manchester, United Kingdom.
[22]
DOI
10.1200/JCO.22.00202
PMID
35709414
发布时间
2023-12-13
换一批
换一批
